136 related articles for article (PubMed ID: 37598478)
21. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.
Zeiser R; Negrin RS
Cell Cycle; 2008 Feb; 7(4):458-62. PubMed ID: 18235249
[TBL] [Abstract][Full Text] [Related]
24. Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.
Thakur K; Janjua D; Shishodia G; Chhokar A; Aggarwal N; Yadav J; Tripathi T; Chaudhary A; Senrung A; Bharti AC
Med Oncol; 2022 Oct; 39(12):255. PubMed ID: 36224441
[TBL] [Abstract][Full Text] [Related]
25. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
26. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
Lei S; Jin J; Zhao X; Zhou L; Qi G; Yang J
Exp Biol Med (Maywood); 2022 Oct; 247(20):1810-1818. PubMed ID: 35733343
[TBL] [Abstract][Full Text] [Related]
27. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.
Kryworuchko M; Pasquier V; Keller H; David D; Goujard C; Gilquin J; Viard JP; Joussemet M; Delfraissy JF; Thèze J
AIDS; 2004 Feb; 18(3):421-6. PubMed ID: 15090793
[TBL] [Abstract][Full Text] [Related]
28. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine.
Smalley Rumfield C; Pellom ST; Morillon Ii YM; Schlom J; Jochems C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554612
[TBL] [Abstract][Full Text] [Related]
32. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
[TBL] [Abstract][Full Text] [Related]
33. Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8
Hernandez R; Toomer KH; Põder J; Santos Savio A; Hsiung S; Malek TR
Cancer Immunol Immunother; 2021 Apr; 70(4):909-921. PubMed ID: 33037893
[TBL] [Abstract][Full Text] [Related]
34. Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing.
Li C; Liu D; Zhao Y; Ding Y; Hua K
J Med Virol; 2023 Jun; 95(6):e28857. PubMed ID: 37287196
[TBL] [Abstract][Full Text] [Related]
35. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-induced MIF induces dysregulation of lipid metabolism in Hep2 laryngocarcinoma through the IL-6/JAK-STAT pathway.
Yang M; Wu S; Cai W; Ming X; Zhou Y; Chen X
Lipids Health Dis; 2022 Aug; 21(1):82. PubMed ID: 36042480
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.
Kryworuchko M; Pasquier V; Thèze J
Clin Exp Immunol; 2003 Mar; 131(3):422-7. PubMed ID: 12605694
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
39. The IL-2A receptor pathway and its role in lymphocyte differentiation and function.
Li Y; Li X; Geng X; Zhao H
Cytokine Growth Factor Rev; 2022 Oct; 67():66-79. PubMed ID: 35803834
[TBL] [Abstract][Full Text] [Related]
40. Correlation between HPV-negative cervical lesions and cervical microenvironment.
Zheng JJ; Miao JR; Wu Q; Yu CX; Mu L; Song JH
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):855-861. PubMed ID: 33218401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
